Molecular cloning of full-length HIV-1 genomes directly from plasma viral RNA

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 1;12(4):352-7. doi: 10.1097/00042560-199608010-00004.

Abstract

Human immunodeficiency virus type 1 (HIV-1) in plasma reflects the replicating virus population at any point in time in vivo. Studies of the relationship of the complete HIV-1 genome to pathogenesis therefore need to focus on plasma virions. Since dual infections and recombination can occur in vivo, cloning an intact plasma virus genome as a single full-length molecule is desirable. For these reasons, we developed an efficient method to clone full-length HIV-1 genomes directly from plasma viral RNA. This method used reverse transcription and long polymerase chain reaction (PCR) amplification. Virion-associated RNA was isolated from plasma samples and then reverse-transcribed to make cDNA for PCR amplification. Two different strategies were employed to amplify the full-length genome: one amplified a 9-kb fragment, and the other amplified two overlapping 5-kb fragments. Although both strategies were successful, the second was preferable for amplifying HIV-1 genomes from samples with low viral titers. By directly ligating the PCR-derived fragments into a phagemid vector, we constructed clones that comprised full-length HIV-1 RNA genomes. Using this technique, we have constructed hundreds of clones containing full-length HIV-1 genomes derived from the plasma of HIV-1-infected individuals, some of whom had low HIV-1 titers. Different HIV-1 molecular species were cloned from a single clinical sample, as demonstrated by restriction site polymorphism. This method provides a tool for studying complete HIV-1 genomes in relation to pathogenic processes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Base Sequence
  • Cloning, Molecular*
  • DNA Primers / chemistry
  • DNA, Complementary / biosynthesis
  • DNA, Complementary / chemistry
  • DNA, Viral / biosynthesis
  • DNA, Viral / chemistry
  • Genome, Viral*
  • HIV Envelope Protein gp120 / genetics
  • HIV Infections / virology
  • HIV-1 / genetics*
  • Humans
  • Molecular Sequence Data
  • Peptide Fragments / genetics
  • Polymerase Chain Reaction
  • Polymorphism, Restriction Fragment Length
  • RNA, Viral / blood*
  • RNA, Viral / genetics
  • RNA, Viral / isolation & purification
  • Sequence Alignment
  • Transcription, Genetic
  • Viremia / virology
  • Virion / genetics*

Substances

  • DNA Primers
  • DNA, Complementary
  • DNA, Viral
  • HIV Envelope Protein gp120
  • HIV envelope protein gp120 (305-321)
  • Peptide Fragments
  • RNA, Viral